ERRα-KDM5Cは,乳がんの進行におけるI型インターフェロンシグナル伝達を調節するSTING増強剤の活性を抑制します

Zu-Hui Xu^1,2, Jie Chen^1,3, Ying He⁴

¹Department of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.

Cell death & disease

|February 18, 2026

まとめ

エストロゲン関連受容体アルファ (ERRα) とKDM5Cは,STING強化剤の活性を調節する. ERRαを減少させると,STINGシグナル伝達が活性化し,乳腺腫瘍の成長を抑制する.

科学分野:

分子生物学は分子生物学である.
癌生物学癌生物学について
エピジェネティクスエピジェネティクス

背景:

強化剤の活性調節は,遺伝子発現と細胞機能にとって極めて重要です.
ダイナミックエンハンサーの活動を制御するメカニズムは完全に理解されていません.
STING経路は,免疫反応と癌に関与しています.

研究の目的:

エストロゲン関連受容体アルファ (ERRα) が強化剤の活性を調節する役割を調査する.
遺伝子発現の制御におけるERRαとKDM5Cの相互作用を解明する.
ERRα-KDM5C複合体のSTINGシグナル伝達と乳がんの進行に対する影響を決定する.

主な方法:

活性増強剤でERRαとKDM5Cの併用分析.
乳がん細胞におけるERRαの枯渇に関する研究.
STING増強剤におけるヒストロン変異 (H3K4me3,H3K4me1) の評価.
増強RNA (eRNA) とSTING遺伝子転写の測定.
TBK1-IRF3経路,タイプIインターフェロン (IFN),およびIFN刺激遺伝子 (ISG) の分析.
乳がん細胞成長のインビトロおよびインビボ評価.

主要な成果:

ERRαはKDM5Cと複合体を形成し,STINGロカスを含む活性増強剤を併用しています.
ERRαの減少は,STING増強剤の過活性化 (H3K4me3の増加,H3K4me1の減少,eRNA転写の上昇) に繋がります.
ERRαの減少はSTING遺伝子転写とTBK1-IRF3経路の活性化を促進し,IFNとISGの発現を増加させます.
ERRαの喪失は,部分的にSTINGシグナリング活性化を通じて,乳がん細胞の成長を in vitro および in vivo で大幅に減少させます.

結論:

ERRα-KDM5C複合体は,STING強化剤の活性に対する重要な調節剤として作用する.
ERRα-KDM5C複合体はSTINGシグナリングを制御し,乳がんの進行に影響を与えます.
ERRα-KDM5Cの相互作用をターゲットにすることで,乳がんの治療戦略を提供することができる.

さらに関連する動画

08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

8.7K

08:32

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Published on: March 2, 2014

11.0K

関連する概念動画

01:15

Receptor Downregulation in MVBs

2.9K

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

2.9K

02:34

Inhibition of Cdk Activity

6.1K

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

6.1K

02:15

Experimental RNAi

8.0K

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

8.0K

01:52

Eukaryotic Transcription Inhibitors

11.1K

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...